source
- ‘Money has spoken’: Why Chinese biotech CEOs tell Fierce they’re unfazed about rising US tensionsYou might assume Chinese biotechs are enduring sleepless nights worrying about whether the ramping up of rhetoric in the U.S. is putting their new financial gains in peril. But the companies Fierce…Fierce Biotech · 3d ago↗ source
- FDA approves Bristol Myers' first oral therapy for advanced multiple myeloma, a new drug classThe U.S. Food and Drug Administration gave its nod to an oral medication from Bristol Myers Squibb for patients with advanced multiple myeloma. The drug represents the first member of a novel clas…